Nihon Medi-Physics Receives Manufacturing Approval for PET Radiopharmaceutical FDG Scan Injection.
Tokyo, Japan, July 29, 2005 - (JCNN JCNN Japan Corporate News Network ) - Nihon Medi-Physics announced on July 27 that it has received approval to manufacture FDG FDG Fluorodeoxyglucose
FDG Fundação de Desenvolvimento Gerencial
FDG Franchise Development Group
FDG Function Dependence Graph
FDG Fraud Detection Group
FDG Functional Dependency Gate
FDG Front des Gaulois
FDG Falling Down Giggling Scan Injection (fludeoxyglucose F-18), its proprietary radiopharmaceutical used in positron emission tomography positron emission tomography: see PET scan.
positron emission tomography (PET)
Imaging technique used in diagnosis and biomedical research. (PET), from the Ministry of Health, Labor and Welfare. The new agent is the first PET agent that has been approved in Japan.
Nihon Medi-Physics will launch the product upon completion of the required procedures.
In addition, the company will market FDG Scan-MP Injection, a radiopharmaceutical offered by the Advanced Medical and Pharmaceutical Research Center in Ishikawa, a co-developer of FDG Scan Injection.
Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion